Pseudomonas aeruginosa-catecholamine inotrope interactions: A contributory factor in the development of ventilator-associated pneumonia?

Chest

Volumn 142, Issue 5, 2012, Pages 1200-1210

  Freestone, Primrose P ^a   Hirst, Robert A ^a,b,c   Sandrini, Sara M ^a   Sharaff, Fathima ^a   Fry, Helen ^a   Hyman, Stefan ^b   O'Callaghan, Chris ^a,b,c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c Institute of Lung Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE DERIVATIVE; DOPAMINE; IRON; NORADRENALIN; PHENYLEPHRINE; PYOVERDINE; TOBRAMYCIN; TRANSFERRIN; VASOPRESSIN;

ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BIOFILM; CONTROLLED STUDY; DRUG INTERACTION; ENDOTRACHEAL TUBE; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; RISK FACTOR; UPREGULATION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84868619886     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2614     Document Type: Article

References (41)

1. Koerner RJ. Contribution of endotracheal tubes to the pathogenesis of ventilator-associated pneumonia. J Hosp Infect. 1997;35(2):83-89. (Pubitemid 27141979)
2. Morehead RS, Pinto SJ. Ventilator-associated pneumonia. Arch Intern Med. 2000;160(13):1926-1936. (Pubitemid 30437577)
3. Garau J, Gomez L. Pseudomonas aeruginosa pneumonia. Curr Opin Infect Dis. 2003;16(2):135-143. (Pubitemid 36521026)
4. Ramirez P, Ferrer M, Torres A. Prevention measures for ventilator-associated pneumonia: a new focus on the endotracheal tube. Curr Opin Infect Dis. 2007;20(2):190-197. (Pubitemid 46340803)
5. Shorr AF, Kollef MH. Ventilator-associated pneumonia: insights from recent clinical trials. Chest. 2005;128(5)(suppl 2):583S-591S. (Pubitemid 41692553)
6. Fagon JY, Rello J. Targeted antibiotic management of ventilator- associated pneumonia. Clin Microbiol Infect. 2006;12(s9):17-22. (Pubitemid 44890341)
7. Freestone PP, Sandrini SM, Haigh RD, Lyte M. Microbial endocrinology: how stress influences susceptibility to infection. Trends Microbiol. 2008;16(2):55-64.
8. Lyte M, Ernst S. Catecholamine induced growth of gram negative bacteria. Life Sci. 1992;50(3):203-212.
9. Alverdy J, Holbrook C, Rocha F, et al. Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg. 2000;232(4):480-489.
10. Bailey MT, Engler H, Sheridan JF. Stress induces the translocation of cutaneous and gastrointestinal microflora to secondary lymphoid organs of C57BL/6 mice. J Neuroimmunol. 2006;171(1-2):29-37. (Pubitemid 41832275)
11. Freestone PP, Haigh RD, Williams PH, Lyte M. Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers. FEMS Microbiol Lett. 1999;172(1):53-60. (Pubitemid 29090290)
12. Freestone PP, Williams PH, Haigh RD, Maggs AF, Neal CP, Lyte M. Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock. 2002;18(5):465-470.
13. Lyte M, Freestone PP, Neal CP, et al. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet. 2003;361(9352):130-135. (Pubitemid 36092017)
14. Smythe MA, Melendy S, Jahns B, Dmuchowski C. An exploratory analysis of medication utilization in a medical intensive care unit. Crit Care Med. 1993;21(9):1319-1323. (Pubitemid 23270501)
15. Raymondos K, Panning B, Leuwer M, et al. Absorption and hemodynamic effects of airway administration of adrenaline in patients with severe cardiac disease. Ann Intern Med. 2000;132(10):800-803. (Pubitemid 30317795)
16. Adir Y, Azzam ZS, Lecuona E, et al. Augmentation of endogenous dopamine production increases lung liquid clearance. Am J Respir Crit Care Med. 2004;169(6):757-763. (Pubitemid 38344113)
17. Shindo H, Nakajima E, Kawai K, Miyakoshi N, Tanaka K. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). 3. Absorption, distribution and excretion of D- and L-DOPA-14C in rats following intravenous and oral administration. Chem Pharm Bull (Tokyo). 1973;21(4):817-825.
18. Lucero MT, Squires A. Catecholamine concentrations in rat nasal mucus are modulated by trigeminal stimulation of the nasal cavity. Brain Res. 1998;807(1-2):234-236. (Pubitemid 29005261)
19. Thompson JP, Boyle JR, Thompson MM, Strupish J, Bell PR, Smith G. Cardiovascular and catecholamine responses during endovascular and conventional abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 1999;17(4):326-333. (Pubitemid 29141377)
20. Girbes AR, Patten MT, McCloskey BV, Groeneveld AB, Hoogenberg K. The renal and neurohumoral effects of the addition of low-dose dopamine in septic critically ill patients. Intensive Care Med. 2000;26(11):1685-1689.
21. Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther. 2003;305(3):800-811. (Pubitemid 36617954)
22. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48(suppl 1):5-16.
23. Freestone PP, Haigh RD, Lyte M. Catecholamine inotrope resuscitation of antibiotic-damaged staphylococci and its block ade by specific receptor antagonists. J Infect Dis. 2008;197(7):1044-1052. (Pubitemid 351590034)
24. Adonizio A, Kong KF, Mathee K. Inhibition of quorum sensing-controlled virulence factor production in Pseudomonas aeruginosa by South Florida plant extracts. Antimicrob Agents Chemother. 2008;52(1):198-203.
25. O'Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol. 1998;30(2):295-304. (Pubitemid 28480181)
26. O'Toole GA, Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol. 1998;28(3):449-461. (Pubitemid 28218392)
27. O'Callaghan CL, Sikand K, Rutman A, Hirst RA. The effect of viscous loading on brain ependymal cilia. Neurosci Lett. 2008;439(1):56-60.
28. Hirst RA, Rutman A, Williams G, O'Callaghan C. Ciliated air-liquid cultures as an aid to diagnostic testing of primary ciliary dyskinesia. Chest. 2010;138(6):1441-1447.
29. Lamont IL, Beare PA, Ochsner U, Vasil AI, Vasil ML. Siderophore-mediated signaling regulates virulence factor production in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 2002;99(10):7072-7077. (Pubitemid 34526257)
30. Martinsson A, Bevegård S, Hjemdahl P. Analysis of phenylephrine in plasma: initial data about the concentration-effect relationship. Eur J Clin Pharmacol. 1986;30(4):427-431. (Pubitemid 16088201)
31. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95(5):1122-1125. (Pubitemid 27097820)
32. Russell JA, Walley KR, Singer J, et al VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877-887. (Pubitemid 351397087)
33. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA III. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med. 2001;29(3):487-493. (Pubitemid 32225288)
34. Ratledge C, Dover LG. Iron metabolism in pathogenic bacteria. Annu Rev Microbiol. 2000;54:881-941.
35. Lamont IL, Konings AF, Reid DW. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Biometals. 2009;22(1):53-60.
36. Yang L, Nilsson M, Gjermansen M, Givskov M, Tolker-Nielsen T. Pyoverdine and PQS mediated subpopulation interactions involved in Pseudomonas aeruginosa biofilm formation. Mol Microbiol. 2009;74(6):1380-1392.
37. Moreau-Marquis S, Stanton BA, O'Toole GA. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. Pulm Pharmacol Ther. 2008;21(4):595-599. (Pubitemid 351970710)
38. Mesaros N, Nordmann P, Plésiat P, et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect. 2007;13(6):560-578. (Pubitemid 46730662)
39. Juste RN, Moran L, Hooper J, Soni N. Dopamine clearance in critically ill patients. Intensive Care Med. 1998;24(11):1217-1220. (Pubitemid 28542938)
40. Stannard W, O'Callaghan C. Management of croup. Paediatr Drugs. 2002;4(4):231-240. (Pubitemid 34494028)
41. Schmidt C, Kraft K. Beta-endorphin and catechomaline concentrations during chronic and acute stress in intensive care patients. Eur J Med Res. 1996;1(1):528-532.